Symbols / VRDN Stock $14.33 +0.35% Viridian Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
VRDN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. It develops IGF-1R therapies to treat thyroid eye disease (TED), including Veligrotrug, a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered, and Elegrobart, a low-volume, infrequently dosed subcutaneous IGF-1R. The company also develops an anti-thyroid-stimulating hormone receptor (TSHR) candidate for the treatment of Graves' disease and TED. Its portfolio of engineered inhibitors of the neonatal Fc receptor (FcFn) includes VRDN-006, a highly selective Fc fragment, and VRDN-008, a half-life extended bispecific FcRn inhibitor comprising an GC fragment and an albumin-binding domain designed to prolong IGG suppression. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021. Viridian Therapeutics, Inc. was incorporated in 2010 and is headquartered in Waltham, Massachusetts.

Stock Fundamentals
Scroll to Statements
Market Cap 1.48B Enterprise Value 774.62M Income -281.93M Sales 70.85M Book/sh 5.79 Cash/sh 8.56
Dividend Yield — Payout 0.00% Employees 252 IPO — P/E — Forward P/E -5.93
PEG — P/S 20.85 P/B 2.47 P/C — EV/EBITDA -2.13 EV/Sales 10.93
Quick Ratio 12.37 Current Ratio 12.65 Debt/Eq 7.28 LT Debt/Eq — EPS (ttm) -3.32 EPS next Y -2.42
EPS Growth — Revenue Growth 83.30% Earnings 2026-05-06 ROA -27.67% ROE -49.16% ROIC —
Gross Margin 0.00% Oper. Margin -956.43% Profit Margin 0.00% Shs Outstand 103.07M Shs Float 102.15M Short Float 10.98%
Short Ratio 5.31 Short Interest — 52W High 34.29 52W Low 11.76 Beta 1.17 Avg Volume 2.13M
Volume 1.34M Target Price $33.56 Recom Strong_buy Prev Close $14.28 Price $14.33 Change 0.35%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$33.56
Mean price target
2. Current target
$14.33
Latest analyst target
3. DCF / Fair value
$-28.30
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$14.33
Low
$20.00
High
$50.00
Mean
$33.56

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-21 main Truist Securities Buy → Buy $33
2026-04-08 main Wedbush Outperform → Outperform $31
2026-04-07 main Goldman Sachs Buy → Buy $31
2026-04-07 main RBC Capital Outperform → Outperform $30
2026-04-02 main Evercore ISI Group Outperform → Outperform $32
2026-03-31 main Goldman Sachs Buy → Buy $36
2026-03-31 main Wedbush Outperform → Outperform $37
2026-03-31 main Wells Fargo Equal-Weight → Equal-Weight $20
2026-03-31 main HC Wainwright & Co. Buy → Buy $22
2026-03-30 main Needham Buy → Buy $32
2026-03-11 reit Wedbush Outperform → Outperform $44
2026-02-27 main RBC Capital Outperform → Outperform $42
2026-02-04 reit Needham Buy → Buy $42
2026-02-03 main Wells Fargo Equal-Weight → Equal-Weight $29
2026-01-08 main Truist Securities Buy → Buy $40
2026-01-07 init UBS — → Buy $50
2025-12-23 main Needham Buy → Buy $42
2025-12-10 main Wedbush Outperform → Outperform $47
2025-12-03 init William Blair — → Outperform —
2025-11-24 init Truist Securities — → Buy $41
News
RSS: Latest VRDN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-03 BEETHAM THOMAS W Chief Operating Officer — 9,409 — —
2026-03-03 MAHONEY STEPHEN F Chief Executive Officer — 18,357 — —
2026-03-03 HARMON SETH Chief Financial Officer — 6,267 — —
2026-03-03 HARMON SETH Chief Financial Officer — 6,267 — —
2026-03-03 TOUSIGNANT JENNIFER Officer — 5,169 — —
2025-12-31 TOUSIGNANT JENNIFER Officer — 2,272 $31.16 $70,796
2025-10-23 FAIRMOUNT FUNDS MANAGEMENT LLC Director and Beneficial Owner of more than 10% of a Class of Security — 454,545 $22.00 $9,999,990
2025-06-10 FAIRMOUNT FUNDS MANAGEMENT LLC Beneficial Owner of more than 10% of a Class of Security — 14,100 $7.80 $166,355
2024-09-27 BEETHAM THOMAS W Chief Operating Officer — 5,000 $23.41 $117,050
2024-09-27 MAHONEY STEPHEN F Chief Executive Officer — 21,400 $23.33 $499,262
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
70.85
+23359.93%
0.30
-3.82%
0.31
-82.28%
1.77
Operating Revenue
70.85
+23359.93%
0.30
-3.82%
0.31
-82.28%
1.77
Operating Expense
434.24
+45.07%
299.34
+17.50%
254.76
+87.22%
136.08
Research And Development
338.93
+42.26%
238.25
+49.13%
159.76
+58.35%
100.89
Selling General And Administration
95.31
+56.04%
61.08
-35.70%
95.00
+170.02%
35.18
General And Administrative Expense
95.31
+56.04%
61.08
-35.70%
95.00
+170.02%
35.18
Other Gand A
95.31
+56.04%
61.08
-35.70%
95.00
+170.02%
35.18
Total Expenses
434.24
+45.07%
299.34
+17.50%
254.76
+87.22%
136.08
Operating Income
-363.39
-21.52%
-299.04
-17.52%
-254.45
-89.46%
-134.30
Total Operating Income As Reported
-363.39
-21.52%
-299.04
-17.52%
-254.45
-89.46%
-134.30
EBITDA
-337.19
-26.19%
-267.21
-13.28%
-235.88
-82.67%
-129.13
Normalized EBITDA
-337.19
-26.19%
-267.21
-13.28%
-235.88
-82.67%
-129.13
Reconciled Depreciation
0.46
-14.81%
0.54
+3.45%
0.52
+104.71%
0.26
EBIT
-337.65
-26.11%
-267.75
-13.26%
-236.40
-82.71%
-129.39
Total Unusual Items
—
—
—
—
Total Unusual Items Excluding Goodwill
—
—
—
—
Special Income Charges
—
—
—
—
Net Income
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Pretax Income
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Net Non Operating Interest Income Expense
22.45
-23.64%
29.40
+73.87%
16.91
+281.69%
4.43
Interest Expense Non Operating
4.95
+125.22%
2.20
+65.06%
1.33
+173.87%
0.49
Net Interest Income
22.45
-23.64%
29.40
+73.87%
16.91
+281.69%
4.43
Interest Expense
4.95
+125.22%
2.20
+65.06%
1.33
+173.87%
0.49
Interest Income Non Operating
27.40
-13.29%
31.60
+73.23%
18.24
+271.03%
4.92
Interest Income
27.40
-13.29%
31.60
+73.23%
18.24
+271.03%
4.92
Other Income Expense
-1.66
-427.71%
-0.31
-62.69%
-0.19
—
Other Non Operating Income Expenses
-1.66
-427.71%
-0.31
-62.69%
-0.19
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Net Income From Continuing Operation Net Minority Interest
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Net Income From Continuing And Discontinued Operation
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Net Income Continuous Operations
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Normalized Income
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Net Income Common Stockholders
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Diluted EPS
-3.32
-8.14%
-3.07
+42.18%
-5.31
-31.11%
-4.05
Basic EPS
-3.32
-8.14%
-3.07
+42.18%
-5.31
-31.11%
-4.05
Basic Average Shares
84.80
+24.92%
67.89
+51.68%
44.76
+39.48%
32.09
Diluted Average Shares
84.80
+24.92%
67.89
+51.68%
44.76
+39.48%
32.09
Diluted NI Availto Com Stockholders
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
899.42
+21.15%
742.40
+51.38%
490.42
+12.72%
435.09
Current Assets
894.23
+21.09%
738.46
+51.80%
486.48
+12.83%
431.17
Cash Cash Equivalents And Short Term Investments
874.65
+21.89%
717.58
+50.32%
477.37
+12.44%
424.55
Cash And Cash Equivalents
212.38
+113.25%
99.59
-3.14%
102.83
-33.91%
155.58
Other Short Term Investments
662.27
+7.17%
617.99
+65.00%
374.54
+39.25%
268.97
Receivables
—
0.00
-100.00%
0.10
+0.00%
0.10
Other Receivables
—
—
0.10
+0.00%
0.10
Prepaid Assets
—
—
—
—
Other Current Assets
19.58
-6.21%
20.88
+131.81%
9.01
+38.11%
6.52
Total Non Current Assets
5.18
+31.53%
3.94
-0.10%
3.95
+0.71%
3.92
Net PPE
3.65
+6.04%
3.44
+2.96%
3.34
+13.83%
2.94
Gross PPE
4.87
+3.36%
4.71
+7.20%
4.39
-11.11%
4.94
Accumulated Depreciation
-1.22
+3.95%
-1.27
-20.69%
-1.05
+47.65%
-2.00
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.92
-17.25%
1.11
+22.19%
0.91
-14.29%
1.06
Other Properties
3.68
+9.92%
3.35
+18.86%
2.81
+1.62%
2.77
Leases
0.27
+6.69%
0.25
-62.09%
0.67
-39.80%
1.11
Other Non Current Assets
1.54
+206.59%
0.50
-17.05%
0.60
-38.49%
0.98
Total Liabilities Net Minority Interest
177.25
+150.48%
70.76
+46.20%
48.40
+20.92%
40.03
Current Liabilities
70.70
+47.67%
47.87
+79.74%
26.64
-20.13%
33.35
Payables And Accrued Expenses
49.92
+37.01%
36.44
+144.68%
14.89
-46.00%
27.58
Payables
8.68
+305.18%
2.14
-4.29%
2.24
-84.27%
14.23
Accounts Payable
8.68
+305.18%
2.14
-4.29%
2.24
-84.27%
14.23
Current Accrued Expenses
41.24
+20.25%
34.29
+171.04%
12.65
-5.17%
13.34
Pensionand Other Post Retirement Benefit Plans Current
19.66
+84.78%
10.64
+1.19%
10.51
+120.31%
4.77
Current Debt And Capital Lease Obligation
0.75
+46.78%
0.51
-39.15%
0.84
+37.52%
0.61
Current Capital Lease Obligation
0.75
+46.78%
0.51
-39.15%
0.84
+37.52%
0.61
Current Deferred Liabilities
0.37
+27.43%
0.29
+0.00%
0.29
+0.00%
0.29
Current Deferred Revenue
0.37
+27.43%
0.29
+0.00%
0.29
+0.00%
0.29
Other Current Liabilities
—
0.10
+0.00%
0.10
+0.00%
0.10
Total Non Current Liabilities Net Minority Interest
106.56
+365.51%
22.89
+5.16%
21.77
+225.95%
6.68
Long Term Debt And Capital Lease Obligation
49.94
+142.64%
20.58
+1.87%
20.20
+334.98%
4.64
Long Term Debt
49.94
+142.64%
20.58
+1.87%
20.20
+334.98%
4.64
Tradeand Other Payables Non Current
—
—
—
—
Non Current Deferred Liabilities
34.24
0.00
-100.00%
0.57
-33.45%
0.86
Non Current Deferred Revenue
34.24
0.00
-100.00%
0.57
-33.45%
0.86
Other Non Current Liabilities
2.34
+1.43%
2.31
+133.37%
0.99
-15.61%
1.17
Stockholders Equity
722.17
+7.52%
671.64
+51.95%
442.02
+11.89%
395.06
Common Stock Equity
590.11
+22.24%
482.75
+104.99%
235.51
-6.88%
252.92
Capital Stock
133.07
-29.85%
189.69
-8.38%
207.06
+45.24%
142.56
Common Stock
1.02
+25.68%
0.81
+50.00%
0.54
+30.43%
0.41
Preferred Stock
132.06
-30.09%
188.88
-8.54%
206.52
+45.28%
142.15
Share Issued
101.83
+25.72%
80.99
+50.03%
53.99
+30.70%
41.31
Ordinary Shares Number
101.83
+25.72%
80.99
+50.03%
53.99
+30.70%
41.31
Additional Paid In Capital
1,927.10
+30.40%
1,477.81
+53.85%
960.54
+29.62%
741.07
Retained Earnings
-1,338.46
-34.40%
-995.86
-37.19%
-725.91
-48.70%
-488.17
Gains Losses Not Affecting Retained Earnings
0.45
+4570.00%
-0.01
-102.96%
0.34
+186.67%
-0.39
Other Equity Adjustments
0.45
+4570.00%
-0.01
-102.96%
0.34
+186.67%
-0.39
Total Equity Gross Minority Interest
722.17
+7.52%
671.64
+51.95%
442.02
+11.89%
395.06
Total Capitalization
772.11
+11.54%
692.22
+49.76%
462.23
+15.64%
399.71
Working Capital
823.54
+19.25%
690.59
+50.18%
459.84
+15.59%
397.82
Invested Capital
640.05
+27.16%
503.34
+96.84%
255.71
-0.72%
257.56
Total Debt
50.69
+140.31%
21.09
+0.22%
21.05
+300.30%
5.26
Capital Lease Obligations
0.75
+46.78%
0.51
-39.15%
0.84
+37.52%
0.61
Net Tangible Assets
722.17
+7.52%
671.64
+51.95%
442.02
+11.89%
395.06
Tangible Book Value
590.11
+22.24%
482.75
+104.99%
235.51
-6.88%
252.92
Derivative Product Liabilities
20.03
0.00
—
—
Dueto Related Parties Non Current
—
—
—
—
Interest Payable
0.39
+150.00%
0.15
+0.00%
0.15
+294.87%
0.04
Preferred Stock Equity
132.06
-30.09%
188.88
-8.54%
206.52
+45.28%
142.15
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-276.39
-18.97%
-232.32
-26.14%
-184.17
-96.26%
-93.84
Cash Flow From Continuing Operating Activities
-276.39
-18.97%
-232.32
-26.14%
-184.17
-96.26%
-93.84
Net Income From Continuing Operations
-342.60
-26.91%
-269.95
-13.55%
-237.73
-83.05%
-129.87
Depreciation Amortization Depletion
0.46
-14.81%
0.54
+3.45%
0.52
+104.71%
0.26
Depreciation And Amortization
0.46
-14.81%
0.54
+3.45%
0.52
+104.71%
0.26
Other Non Cash Items
4.47
+348.75%
1.00
-85.31%
6.79
+2470.08%
0.26
Stock Based Compensation
44.30
+5.11%
42.15
-37.25%
67.17
+239.85%
19.77
Operating Gains Losses
0.70
+55.90%
0.45
+146.70%
0.18
—
Gain Loss On Investment Securities
0.70
—
—
—
Gain Loss On Sale Of PPE
—
0.45
+44800.00%
0.00
0.00
Change In Working Capital
23.03
+139.96%
9.60
+201.84%
-9.43
-159.05%
15.96
Change In Receivables
—
0.10
0.00
-100.00%
0.35
Change In Prepaid Assets
0.26
+102.25%
-11.67
-453.68%
-2.11
+36.90%
-3.34
Change In Payables And Accrued Expense
22.77
+7.08%
21.26
+390.57%
-7.32
-138.04%
19.24
Change In Accrued Expense
16.21
-24.04%
21.34
+351.86%
4.72
-38.80%
7.72
Change In Payable
6.56
+9089.04%
-0.07
+99.39%
-12.04
-204.48%
11.52
Change In Account Payable
6.56
+9089.04%
-0.07
+99.39%
-12.04
-204.48%
11.52
Change In Other Working Capital
—
-0.29
+0.00%
-0.29
+0.00%
-0.29
Investing Cash Flow
-37.56
+83.57%
-228.65
-142.60%
-94.25
+18.13%
-115.13
Cash Flow From Continuing Investing Activities
-37.56
+83.57%
-228.65
-142.60%
-94.25
+18.13%
-115.13
Net PPE Purchase And Sale
-0.49
+3.13%
-0.51
+43.10%
-0.90
-12.67%
-0.80
Purchase Of PPE
-0.49
+3.13%
-0.51
+43.10%
-0.90
-12.67%
-0.80
Sale Of PPE
—
—
0.00
0.00
Capital Expenditure
-0.49
+3.13%
-0.51
+43.10%
-0.90
-12.67%
-0.80
Net Investment Purchase And Sale
-37.07
+83.75%
-228.14
-144.38%
-93.35
+18.35%
-114.33
Purchase Of Investment
-579.28
+16.66%
-695.07
-70.41%
-407.88
-82.69%
-223.26
Sale Of Investment
542.21
+16.12%
466.93
+48.45%
314.53
+188.73%
108.94
Net Business Purchase And Sale
—
—
—
—
Financing Cash Flow
426.74
-6.77%
457.74
+102.83%
225.67
-29.97%
322.24
Cash Flow From Continuing Financing Activities
426.74
-6.77%
457.74
+102.83%
225.67
-29.97%
322.24
Net Issuance Payments Of Debt
28.88
0.00
-100.00%
15.00
+200.00%
5.00
Issuance Of Debt
28.88
0.00
-100.00%
15.00
+200.00%
5.00
Repayment Of Debt
—
—
—
—
Long Term Debt Issuance
28.88
0.00
-100.00%
15.00
+200.00%
5.00
Long Term Debt Payments
—
—
—
—
Net Long Term Debt Issuance
28.88
0.00
-100.00%
15.00
+200.00%
5.00
Net Common Stock Issuance
352.20
-22.37%
453.66
+262.73%
125.07
-57.15%
291.87
Proceeds From Stock Option Exercised
14.79
+145.76%
6.02
-72.30%
21.72
+459.90%
3.88
Net Other Financing Charges
30.88
+214.62%
-26.94
-118.77%
-12.31
+45.29%
-22.51
Changes In Cash
112.79
+3588.65%
-3.23
+93.87%
-52.75
-146.57%
113.28
Beginning Cash Position
99.59
-3.14%
102.83
-33.91%
155.58
+267.81%
42.30
End Cash Position
212.38
+113.25%
99.59
-3.14%
102.83
-33.91%
155.58
Free Cash Flow
-276.89
-18.92%
-232.83
-25.81%
-185.07
-95.56%
-94.64
Interest Paid Supplemental Data
2.15
+18.13%
1.82
+105.42%
0.89
+202.39%
0.29
Amortization Of Securities
-6.76
+56.83%
-15.65
-36.25%
-11.49
-5371.43%
-0.21
Common Stock Issuance
352.20
-22.37%
453.66
+262.73%
125.07
-57.15%
291.87
Issuance Of Capital Stock
352.20
-26.42%
478.66
+137.83%
201.26
-40.08%
335.87
Net Preferred Stock Issuance
0.00
-100.00%
25.00
-67.19%
76.19
+73.16%
44.00
Preferred Stock Issuance
0.00
-100.00%
25.00
-67.19%
76.19
+73.16%
44.00
Sale Of Business
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category